Esperion Therapeutics | Koszty Operacyjne



Operating Expenses Zmiana Data
AbbVie USD 9.61B 6.98B 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amarin USD 58.77M 56.06M 2025-03
Amgen USD 6.86B 85M 2025-03
Biogen USD 2.12B 106.5M 2025-03
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Cipla INR 55.01B 1.37B 2025-03
CSL USD 5.72B 173M 2024-12
Cytokinetics USD 157.21M 1.24M 2025-03
Daiichi Sankyo JPY 435.08B 11.65B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Geron USD 56.31M 12.99M 2025-03
Grifols EUR 1.6B 128.03M 2024-12
Halozyme Therapeutics USD 123.33M 819K 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Merck USD 9.66B 1.67B 2025-03
Moderna USD 1.16B 1.06B 2025-03
Pfizer USD 10.05B 8.12B 2025-03
PTC Therapeutics USD 205.87M 69.79M 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Sanofi EUR 8.32B 1.55B 2025-03
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
United Therapeutics USD 411.6M 33.4M 2025-03


Esperion Therapeutics Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.